Evariste

AI-based drug discovery platform to target synthetic lethal pathways in oncology

placeLondon, England, United Kingdom calendar_todayFounded 2017 groups9 employees language evariste.com

Registered entities

Innovation

2 patent families; filing pace active.

YearFilings
20241
20251

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%
Coming soon